Targeting MET as a strategy to overcome crosstalk-related resistance to EGFR inhibitors

被引：112

作者：

Karamouzis, Michalis V. ^{[1
]}

Konstantinopoulos, Panagiotis A. ^{[1
,2
]}

Papavassiliou, Athanasios G. ^{[1
]}

机构：

[1] Univ Athens, Dept Biol Chem, Sch Med, Athens 11527, Greece

[2] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Boston, MA USA

来源：

LANCET ONCOLOGY | 2009年 / 10卷 / 07期

关键词：

GROWTH-FACTOR RECEPTOR; CELL LUNG-CANCER; PROTEIN-TYROSINE-PHOSPHATASE; METASTATIC COLORECTAL-CANCER; C-MET; ACQUIRED-RESISTANCE; NEUTRALIZING ANTIBODY; GEFITINIB RESISTANCE; KINASE INHIBITORS; INVASIVE GROWTH;

D O I：

10.1016/S1470-2045(09)70137-8

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The hepatocyte growth factor (HGF)-mesenchymal-epithelial transition factor (MET) pathway has a key role in carcinogenesis; it is implicated in proliferation, inhibition of apoptosis, angiogenesis, migration, invasiveness, and metastasis. All of these molecular events are driven through membrane and intracellular coplayers and several downstream effector proteins. MET has been shown to cross react with epithelial growth factor receptor (EGFR) proteins and possibly substitutes their activity, thus conferring resistance to EGFR-targeting drugs. Therefore, identification of MET inhibitors might lead to new treatments for MET-triggered neoplasia and improve the sensitivity of molecularly targeted antineoplastic compounds that are currently in use. In this Review, we outline current data regarding the HGF-MET pathway during carcinogenesis and the strategies for therapeutic targeting of this pathway. We also discuss the rationale and future perspectives of the combinatorial blockade of HGF-MET and EGFR signalling cascades in cancer treatment.

引用

页码：709 / 717

页数：9

共 75 条

[1] Potent blockade of hepatocyte growth factor-stimulated cell motility, matrix invasion and branching morphogenesis by antagonists of Grb2 Src homology 2 domain interactions [J].

Atabey, N ;

Gao, Y ;

Yao, ZJ ;

Breckenridge, D ;

Soon, L ;

Soriano, JV ;

Burke, TR ;

Bottaro, DP .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (17) :14308-14314

[2] HER kinase activation confers resistance to MET tyrosine kinase inhibition in MET oncogene-addicted gastric cancer cells [J].

Bachleitner-Hofmann, Thomas ;

Sun, Mark Y. ;

Chen, Chin-Tung ;

Tang, Laura ;

Song, Lin ;

Zeng, Zhaoshi ;

Shah, Manish ;

Christensen, James G. ;

Rosen, Neal ;

Solit, David B. ;

Weiser, Martin R. .

MOLECULAR CANCER THERAPEUTICS, 2008, 7 (11) :3499-3508

[3] Non-palpable breast carcinomas: Correlation of mammographically detected malignant-appearing microcalcifications and epidermal growth factor receptor (EGFR) family expression [J].

Badra, Filitsa A. ;

Karamouzis, Michalis V. ;

Ravazoula, Panagiota ;

Likaki-Karatza, Eleni ;

Tzorakoleftherakis, Evagelos ;

Koukouras, Dimitrios ;

Iconomou, Gregorios ;

Xiros, Nikolaos ;

Siablis, Dimitrios ;

Papavassiliou, Athanasios G. ;

Kalofonos, Haralabos P. .

CANCER LETTERS, 2006, 244 (01) :34-41

[4] Novel D761Y and common secondary T790M mutations in epidermal growth factor receptor - Mutant lung adenocarcinomas with acquired resistance to kinase inhibitors [J].

Balak, Marissa N. ;

Gong, Yixuan ;

Riely, Gregory J. ;

Somwar, Romel ;

Li, Allan R. ;

Zakowski, Maureen F. ;

Chiang, Anne ;

Yang, Guangli ;

Ouerfelli, Ouathek ;

Kris, Mark G. ;

Ladanyi, Marc ;

Miller, Vincent A. ;

Pao, William .

CLINICAL CANCER RESEARCH, 2006, 12 (21) :6494-6501

[5] High-Throughput Analysis of HGF-Stimulated Cell Scattering [J].

Chan, Grace K. Y. ;

Lutterbach, Bart A. ;

Pan, Bo-Sheng ;

Kariv, Ilona ;

Szewczak, Alexander A. .

JOURNAL OF BIOMOLECULAR SCREENING, 2008, 13 (09) :847-854

[6] c-Met is essential for wound healing in the skin [J].

Chmielowiec, Jolanta ;

Borowiak, Malgorzata ;

Morkel, Markus ;

Stradal, Theresia ;

Munz, Barbara ;

Werner, Sabine ;

Wehland, Juergen ;

Birchmeier, Carmen ;

Birchmeier, Walter .

JOURNAL OF CELL BIOLOGY, 2007, 177 (01) :151-162

[7] c-Met-targeted RNA interference inhibits growth and metastasis of glioma U251 cells in vitro [J].

Chu, Sheng-Hua ;

Feng, Dong-Fu ;

Zhang, Hong ;

Chen, Er-Tao ;

Duan, Zhi-Xin ;

Li, Xue-Yuan ;

Li, Jia ;

Ma, Yan-Bin ;

Zhu, Zhi-An ;

Qiu, Jian-Hua .

JOURNAL OF NEURO-ONCOLOGY, 2009, 93 (02) :183-189

[8] EGF-ERBB signalling: towards the systems level [J].

Citri, Ami ;

Yarden, Yosef .

NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2006, 7 (07) :505-516

[9] Drug development of MET inhibitors: targeting oncogene addiction and expedience [J].

Comoglio, Paolo M. ;

Giordano, Silvia ;

Trusolino, Livio .

NATURE REVIEWS DRUG DISCOVERY, 2008, 7 (06) :504-516

[10] MOLECULAR-CLONING OF A NEW TRANSFORMING GENE FROM A CHEMICALLY TRANSFORMED HUMAN CELL-LINE [J].

COOPER, CS ;

PARK, M ;

BLAIR, DG ;

TAINSKY, MA ;

HUEBNER, K ;

CROCE, CM ;

VANDEWOUDE, GF .

NATURE, 1984, 311 (5981) :29-33

← 1 2 3 4 5 6 7 8 →